These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4056986)

  • 21. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T; Bigley J
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.
    Weinberger M; Hendeles L
    Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of a sustained-release theophylline preparation in infants and preschool children with asthma.
    Isles AF; Newth CJ
    J Allergy Clin Immunol; 1985 Mar; 75(3):377-81. PubMed ID: 3973312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL; Schaber DE; Wyatt RA
    Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Day-night differences in steady-state theophylline pharmacokinetics in asthmatic children.
    Scott PH; Kramer WG; Smolensky MH; Harrist RB; Hiatt PW; Baenziger JC; Klank BJ; Eigen H
    Chronobiol Int; 1989; 6(2):163-71. PubMed ID: 2743469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erratic absorption of theophylline from slow-release products in children.
    Szefler SJ
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):710-5. PubMed ID: 3534052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a new sustained-release theophylline tablet for children.
    Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
    Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of sustained-release theophylline granules in apple sauce in pediatric asthmatic patients.
    Lotner GZ; Vanderpool GE; Carroll S; Tinkelman DG; Spangler DL
    Ann Allergy; 1983 Jan; 50(1):27-9. PubMed ID: 6849516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained-release theophylline for treatment of asthma in preschool children.
    Simons FE; Luciuk GH; Simons KJ
    Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The absorption characteristics of six sustained-release theophylline preparations.
    Sommers DK; van Wyk M; Meyer EC; Snyman JR; Moncrieff J
    S Afr Med J; 1992 Jan; 81(1):20-2. PubMed ID: 1729729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food induced changes in theophylline absorption from a once-a-day theophylline product.
    Steffensen G; Pedersen S
    Br J Clin Pharmacol; 1986 Nov; 22(5):571-7. PubMed ID: 3790404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum theophylline levels in young children receiving a sustained-release theophylline tablet.
    Howard ML; Baldwin JN; Kobayashi RH; Jensen BK
    J Asthma; 1984; 21(5):299-303. PubMed ID: 6501169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics.
    Munch EP; Søndergaard I; Weeke B
    Allergy; 1981 Feb; 36(2):89-98. PubMed ID: 7235205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.